Global Pruritus Therapeutics Market Analysis and Forecast 2024-2030
Summary
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
According to APO Research, The global Pruritus Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Pruritus Therapeutics include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma and GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pruritus Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pruritus Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Pruritus Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pruritus Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pruritus Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pruritus Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Pruritus Therapeutics segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pruritus Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pruritus Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pruritus Therapeutics revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
According to APO Research, The global Pruritus Therapeutics market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Pruritus Therapeutics is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Pruritus Therapeutics include J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma and GlaxoSmithKline, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Pruritus Therapeutics, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Pruritus Therapeutics, also provides the revenue of main regions and countries. Of the upcoming market potential for Pruritus Therapeutics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pruritus Therapeutics revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Pruritus Therapeutics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Pruritus Therapeutics revenue, projected growth trends, production technology, application and end-user industry.
Pruritus Therapeutics segment by Company
- J&J
- Abbott
- Amgen
- LEO Pharma
- Novartis
- Bayer
- Pfizer
- UCB Pharma
- GlaxoSmithKline
- Galderma
- Huapont
- Antihistamines
- Corticosteroids
- Calcineurin Inhibitors
- Others
- External Use
- Oral
- Injection
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pruritus Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pruritus Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pruritus Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Pruritus Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Pruritus Therapeutics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pruritus Therapeutics revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Pruritus Therapeutics Market by Type
1.2.1 Global Pruritus Therapeutics Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Calcineurin Inhibitors
1.2.5 Others
1.3 Pruritus Therapeutics Market by Application
1.3.1 Global Pruritus Therapeutics Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 PRURITUS THERAPEUTICS MARKET DYNAMICS
2.1 Pruritus Therapeutics Industry Trends
2.2 Pruritus Therapeutics Industry Drivers
2.3 Pruritus Therapeutics Industry Opportunities and Challenges
2.4 Pruritus Therapeutics Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global Pruritus Therapeutics Market Perspective (2019-2030)
3.2 Global Pruritus Therapeutics Growth Trends by Region
3.2.1 Global Pruritus Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Pruritus Therapeutics Market Size by Region (2019-2024)
3.2.3 Global Pruritus Therapeutics Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global Pruritus Therapeutics Revenue by Players
4.1.1 Global Pruritus Therapeutics Revenue by Players (2019-2024)
4.1.2 Global Pruritus Therapeutics Revenue Market Share by Players (2019-2024)
4.1.3 Global Pruritus Therapeutics Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Pruritus Therapeutics Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Pruritus Therapeutics Key Players Headquarters & Area Served
4.4 Global Pruritus Therapeutics Players, Product Type & Application
4.5 Global Pruritus Therapeutics Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Pruritus Therapeutics Market CR5 and HHI
4.6.2 Global Top 5 and 10 Pruritus Therapeutics Players Market Share by Revenue in 2023
4.6.3 2023 Pruritus Therapeutics Tier 1, Tier 2, and Tier
5 PRURITUS THERAPEUTICS MARKET SIZE BY TYPE
5.1 Global Pruritus Therapeutics Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Pruritus Therapeutics Revenue by Type (2019-2030)
5.3 Global Pruritus Therapeutics Revenue Market Share by Type (2019-2030)
6 PRURITUS THERAPEUTICS MARKET SIZE BY APPLICATION
6.1 Global Pruritus Therapeutics Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Pruritus Therapeutics Revenue by Application (2019-2030)
6.3 Global Pruritus Therapeutics Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 J&J
7.1.1 J&J Comapny Information
7.1.2 J&J Business Overview
7.1.3 J&J Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.1.4 J&J Pruritus Therapeutics Product Portfolio
7.1.5 J&J Recent Developments
7.2 Abbott
7.2.1 Abbott Comapny Information
7.2.2 Abbott Business Overview
7.2.3 Abbott Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Pruritus Therapeutics Product Portfolio
7.2.5 Abbott Recent Developments
7.3 Amgen
7.3.1 Amgen Comapny Information
7.3.2 Amgen Business Overview
7.3.3 Amgen Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.3.4 Amgen Pruritus Therapeutics Product Portfolio
7.3.5 Amgen Recent Developments
7.4 LEO Pharma
7.4.1 LEO Pharma Comapny Information
7.4.2 LEO Pharma Business Overview
7.4.3 LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.4.4 LEO Pharma Pruritus Therapeutics Product Portfolio
7.4.5 LEO Pharma Recent Developments
7.5 Novartis
7.5.1 Novartis Comapny Information
7.5.2 Novartis Business Overview
7.5.3 Novartis Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.5.4 Novartis Pruritus Therapeutics Product Portfolio
7.5.5 Novartis Recent Developments
7.6 Bayer
7.6.1 Bayer Comapny Information
7.6.2 Bayer Business Overview
7.6.3 Bayer Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.6.4 Bayer Pruritus Therapeutics Product Portfolio
7.6.5 Bayer Recent Developments
7.7 Pfizer
7.7.1 Pfizer Comapny Information
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.7.4 Pfizer Pruritus Therapeutics Product Portfolio
7.7.5 Pfizer Recent Developments
7.8 UCB Pharma
7.8.1 UCB Pharma Comapny Information
7.8.2 UCB Pharma Business Overview
7.8.3 UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.8.4 UCB Pharma Pruritus Therapeutics Product Portfolio
7.8.5 UCB Pharma Recent Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Comapny Information
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.9.4 GlaxoSmithKline Pruritus Therapeutics Product Portfolio
7.9.5 GlaxoSmithKline Recent Developments
7.10 Galderma
7.10.1 Galderma Comapny Information
7.10.2 Galderma Business Overview
7.10.3 Galderma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.10.4 Galderma Pruritus Therapeutics Product Portfolio
7.10.5 Galderma Recent Developments
7.11 Huapont
7.11.1 Huapont Comapny Information
7.11.2 Huapont Business Overview
7.11.3 Huapont Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.11.4 Huapont Pruritus Therapeutics Product Portfolio
7.11.5 Huapont Recent Developments
8 NORTH AMERICA
8.1 North America Pruritus Therapeutics Revenue (2019-2030)
8.2 North America Pruritus Therapeutics Revenue by Type (2019-2030)
8.2.1 North America Pruritus Therapeutics Revenue by Type (2019-2024)
8.2.2 North America Pruritus Therapeutics Revenue by Type (2025-2030)
8.3 North America Pruritus Therapeutics Revenue Share by Type (2019-2030)
8.4 North America Pruritus Therapeutics Revenue by Application (2019-2030)
8.4.1 North America Pruritus Therapeutics Revenue by Application (2019-2024)
8.4.2 North America Pruritus Therapeutics Revenue by Application (2025-2030)
8.5 North America Pruritus Therapeutics Revenue Share by Application (2019-2030)
8.6 North America Pruritus Therapeutics Revenue by Country
8.6.1 North America Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Pruritus Therapeutics Revenue by Country (2019-2024)
8.6.3 North America Pruritus Therapeutics Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe Pruritus Therapeutics Revenue (2019-2030)
9.2 Europe Pruritus Therapeutics Revenue by Type (2019-2030)
9.2.1 Europe Pruritus Therapeutics Revenue by Type (2019-2024)
9.2.2 Europe Pruritus Therapeutics Revenue by Type (2025-2030)
9.3 Europe Pruritus Therapeutics Revenue Share by Type (2019-2030)
9.4 Europe Pruritus Therapeutics Revenue by Application (2019-2030)
9.4.1 Europe Pruritus Therapeutics Revenue by Application (2019-2024)
9.4.2 Europe Pruritus Therapeutics Revenue by Application (2025-2030)
9.5 Europe Pruritus Therapeutics Revenue Share by Application (2019-2030)
9.6 Europe Pruritus Therapeutics Revenue by Country
9.6.1 Europe Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Pruritus Therapeutics Revenue by Country (2019-2024)
9.6.3 Europe Pruritus Therapeutics Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China Pruritus Therapeutics Revenue (2019-2030)
10.2 China Pruritus Therapeutics Revenue by Type (2019-2030)
10.2.1 China Pruritus Therapeutics Revenue by Type (2019-2024)
10.2.2 China Pruritus Therapeutics Revenue by Type (2025-2030)
10.3 China Pruritus Therapeutics Revenue Share by Type (2019-2030)
10.4 China Pruritus Therapeutics Revenue by Application (2019-2030)
10.4.1 China Pruritus Therapeutics Revenue by Application (2019-2024)
10.4.2 China Pruritus Therapeutics Revenue by Application (2025-2030)
10.5 China Pruritus Therapeutics Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Pruritus Therapeutics Revenue (2019-2030)
11.2 Asia Pruritus Therapeutics Revenue by Type (2019-2030)
11.2.1 Asia Pruritus Therapeutics Revenue by Type (2019-2024)
11.2.2 Asia Pruritus Therapeutics Revenue by Type (2025-2030)
11.3 Asia Pruritus Therapeutics Revenue Share by Type (2019-2030)
11.4 Asia Pruritus Therapeutics Revenue by Application (2019-2030)
11.4.1 Asia Pruritus Therapeutics Revenue by Application (2019-2024)
11.4.2 Asia Pruritus Therapeutics Revenue by Application (2025-2030)
11.5 Asia Pruritus Therapeutics Revenue Share by Application (2019-2030)
11.6 Asia Pruritus Therapeutics Revenue by Country
11.6.1 Asia Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Pruritus Therapeutics Revenue by Country (2019-2024)
11.6.3 Asia Pruritus Therapeutics Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA Pruritus Therapeutics Revenue (2019-2030)
12.2 MEALA Pruritus Therapeutics Revenue by Type (2019-2030)
12.2.1 MEALA Pruritus Therapeutics Revenue by Type (2019-2024)
12.2.2 MEALA Pruritus Therapeutics Revenue by Type (2025-2030)
12.3 MEALA Pruritus Therapeutics Revenue Share by Type (2019-2030)
12.4 MEALA Pruritus Therapeutics Revenue by Application (2019-2030)
12.4.1 MEALA Pruritus Therapeutics Revenue by Application (2019-2024)
12.4.2 MEALA Pruritus Therapeutics Revenue by Application (2025-2030)
12.5 MEALA Pruritus Therapeutics Revenue Share by Application (2019-2030)
12.6 MEALA Pruritus Therapeutics Revenue by Country
12.6.1 MEALA Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Pruritus Therapeutics Revenue by Country (2019-2024)
12.6.3 MEALA Pruritus Therapeutics Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
1.1 Product Definition
1.2 Pruritus Therapeutics Market by Type
1.2.1 Global Pruritus Therapeutics Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Calcineurin Inhibitors
1.2.5 Others
1.3 Pruritus Therapeutics Market by Application
1.3.1 Global Pruritus Therapeutics Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 PRURITUS THERAPEUTICS MARKET DYNAMICS
2.1 Pruritus Therapeutics Industry Trends
2.2 Pruritus Therapeutics Industry Drivers
2.3 Pruritus Therapeutics Industry Opportunities and Challenges
2.4 Pruritus Therapeutics Industry Restraints
3 GLOBAL GROWTH PERSPECTIVE
3.1 Global Pruritus Therapeutics Market Perspective (2019-2030)
3.2 Global Pruritus Therapeutics Growth Trends by Region
3.2.1 Global Pruritus Therapeutics Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Pruritus Therapeutics Market Size by Region (2019-2024)
3.2.3 Global Pruritus Therapeutics Market Size by Region (2025-2030)
4 COMPETITIVE LANDSCAPE BY PLAYERS
4.1 Global Pruritus Therapeutics Revenue by Players
4.1.1 Global Pruritus Therapeutics Revenue by Players (2019-2024)
4.1.2 Global Pruritus Therapeutics Revenue Market Share by Players (2019-2024)
4.1.3 Global Pruritus Therapeutics Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Pruritus Therapeutics Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Pruritus Therapeutics Key Players Headquarters & Area Served
4.4 Global Pruritus Therapeutics Players, Product Type & Application
4.5 Global Pruritus Therapeutics Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Pruritus Therapeutics Market CR5 and HHI
4.6.2 Global Top 5 and 10 Pruritus Therapeutics Players Market Share by Revenue in 2023
4.6.3 2023 Pruritus Therapeutics Tier 1, Tier 2, and Tier
5 PRURITUS THERAPEUTICS MARKET SIZE BY TYPE
5.1 Global Pruritus Therapeutics Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Pruritus Therapeutics Revenue by Type (2019-2030)
5.3 Global Pruritus Therapeutics Revenue Market Share by Type (2019-2030)
6 PRURITUS THERAPEUTICS MARKET SIZE BY APPLICATION
6.1 Global Pruritus Therapeutics Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Pruritus Therapeutics Revenue by Application (2019-2030)
6.3 Global Pruritus Therapeutics Revenue Market Share by Application (2019-2030)
7 COMPANY PROFILES
7.1 J&J
7.1.1 J&J Comapny Information
7.1.2 J&J Business Overview
7.1.3 J&J Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.1.4 J&J Pruritus Therapeutics Product Portfolio
7.1.5 J&J Recent Developments
7.2 Abbott
7.2.1 Abbott Comapny Information
7.2.2 Abbott Business Overview
7.2.3 Abbott Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Pruritus Therapeutics Product Portfolio
7.2.5 Abbott Recent Developments
7.3 Amgen
7.3.1 Amgen Comapny Information
7.3.2 Amgen Business Overview
7.3.3 Amgen Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.3.4 Amgen Pruritus Therapeutics Product Portfolio
7.3.5 Amgen Recent Developments
7.4 LEO Pharma
7.4.1 LEO Pharma Comapny Information
7.4.2 LEO Pharma Business Overview
7.4.3 LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.4.4 LEO Pharma Pruritus Therapeutics Product Portfolio
7.4.5 LEO Pharma Recent Developments
7.5 Novartis
7.5.1 Novartis Comapny Information
7.5.2 Novartis Business Overview
7.5.3 Novartis Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.5.4 Novartis Pruritus Therapeutics Product Portfolio
7.5.5 Novartis Recent Developments
7.6 Bayer
7.6.1 Bayer Comapny Information
7.6.2 Bayer Business Overview
7.6.3 Bayer Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.6.4 Bayer Pruritus Therapeutics Product Portfolio
7.6.5 Bayer Recent Developments
7.7 Pfizer
7.7.1 Pfizer Comapny Information
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.7.4 Pfizer Pruritus Therapeutics Product Portfolio
7.7.5 Pfizer Recent Developments
7.8 UCB Pharma
7.8.1 UCB Pharma Comapny Information
7.8.2 UCB Pharma Business Overview
7.8.3 UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.8.4 UCB Pharma Pruritus Therapeutics Product Portfolio
7.8.5 UCB Pharma Recent Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Comapny Information
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.9.4 GlaxoSmithKline Pruritus Therapeutics Product Portfolio
7.9.5 GlaxoSmithKline Recent Developments
7.10 Galderma
7.10.1 Galderma Comapny Information
7.10.2 Galderma Business Overview
7.10.3 Galderma Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.10.4 Galderma Pruritus Therapeutics Product Portfolio
7.10.5 Galderma Recent Developments
7.11 Huapont
7.11.1 Huapont Comapny Information
7.11.2 Huapont Business Overview
7.11.3 Huapont Pruritus Therapeutics Revenue and Gross Margin (2019-2024)
7.11.4 Huapont Pruritus Therapeutics Product Portfolio
7.11.5 Huapont Recent Developments
8 NORTH AMERICA
8.1 North America Pruritus Therapeutics Revenue (2019-2030)
8.2 North America Pruritus Therapeutics Revenue by Type (2019-2030)
8.2.1 North America Pruritus Therapeutics Revenue by Type (2019-2024)
8.2.2 North America Pruritus Therapeutics Revenue by Type (2025-2030)
8.3 North America Pruritus Therapeutics Revenue Share by Type (2019-2030)
8.4 North America Pruritus Therapeutics Revenue by Application (2019-2030)
8.4.1 North America Pruritus Therapeutics Revenue by Application (2019-2024)
8.4.2 North America Pruritus Therapeutics Revenue by Application (2025-2030)
8.5 North America Pruritus Therapeutics Revenue Share by Application (2019-2030)
8.6 North America Pruritus Therapeutics Revenue by Country
8.6.1 North America Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Pruritus Therapeutics Revenue by Country (2019-2024)
8.6.3 North America Pruritus Therapeutics Revenue by Country (2025-2030)
8.6.4 U.S.
8.6.5 Canada
9 EUROPE
9.1 Europe Pruritus Therapeutics Revenue (2019-2030)
9.2 Europe Pruritus Therapeutics Revenue by Type (2019-2030)
9.2.1 Europe Pruritus Therapeutics Revenue by Type (2019-2024)
9.2.2 Europe Pruritus Therapeutics Revenue by Type (2025-2030)
9.3 Europe Pruritus Therapeutics Revenue Share by Type (2019-2030)
9.4 Europe Pruritus Therapeutics Revenue by Application (2019-2030)
9.4.1 Europe Pruritus Therapeutics Revenue by Application (2019-2024)
9.4.2 Europe Pruritus Therapeutics Revenue by Application (2025-2030)
9.5 Europe Pruritus Therapeutics Revenue Share by Application (2019-2030)
9.6 Europe Pruritus Therapeutics Revenue by Country
9.6.1 Europe Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Pruritus Therapeutics Revenue by Country (2019-2024)
9.6.3 Europe Pruritus Therapeutics Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 CHINA
10.1 China Pruritus Therapeutics Revenue (2019-2030)
10.2 China Pruritus Therapeutics Revenue by Type (2019-2030)
10.2.1 China Pruritus Therapeutics Revenue by Type (2019-2024)
10.2.2 China Pruritus Therapeutics Revenue by Type (2025-2030)
10.3 China Pruritus Therapeutics Revenue Share by Type (2019-2030)
10.4 China Pruritus Therapeutics Revenue by Application (2019-2030)
10.4.1 China Pruritus Therapeutics Revenue by Application (2019-2024)
10.4.2 China Pruritus Therapeutics Revenue by Application (2025-2030)
10.5 China Pruritus Therapeutics Revenue Share by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Pruritus Therapeutics Revenue (2019-2030)
11.2 Asia Pruritus Therapeutics Revenue by Type (2019-2030)
11.2.1 Asia Pruritus Therapeutics Revenue by Type (2019-2024)
11.2.2 Asia Pruritus Therapeutics Revenue by Type (2025-2030)
11.3 Asia Pruritus Therapeutics Revenue Share by Type (2019-2030)
11.4 Asia Pruritus Therapeutics Revenue by Application (2019-2030)
11.4.1 Asia Pruritus Therapeutics Revenue by Application (2019-2024)
11.4.2 Asia Pruritus Therapeutics Revenue by Application (2025-2030)
11.5 Asia Pruritus Therapeutics Revenue Share by Application (2019-2030)
11.6 Asia Pruritus Therapeutics Revenue by Country
11.6.1 Asia Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Pruritus Therapeutics Revenue by Country (2019-2024)
11.6.3 Asia Pruritus Therapeutics Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 MIDDLE EAST, AFRICA, LATIN AMERICA
12.1 MEALA Pruritus Therapeutics Revenue (2019-2030)
12.2 MEALA Pruritus Therapeutics Revenue by Type (2019-2030)
12.2.1 MEALA Pruritus Therapeutics Revenue by Type (2019-2024)
12.2.2 MEALA Pruritus Therapeutics Revenue by Type (2025-2030)
12.3 MEALA Pruritus Therapeutics Revenue Share by Type (2019-2030)
12.4 MEALA Pruritus Therapeutics Revenue by Application (2019-2030)
12.4.1 MEALA Pruritus Therapeutics Revenue by Application (2019-2024)
12.4.2 MEALA Pruritus Therapeutics Revenue by Application (2025-2030)
12.5 MEALA Pruritus Therapeutics Revenue Share by Application (2019-2030)
12.6 MEALA Pruritus Therapeutics Revenue by Country
12.6.1 MEALA Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Pruritus Therapeutics Revenue by Country (2019-2024)
12.6.3 MEALA Pruritus Therapeutics Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 CONCLUDING INSIGHTS
14 APPENDIX
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
LIST OF TABLES
Table 1. Global Pruritus Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Antihistamines Major Manufacturers
Table 2. Corticosteroids Major Manufacturers
Table 3. Calcineurin Inhibitors Major Manufacturers
Table 4. Others Major Manufacturers
Table 5. Global Pruritus Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. External Use Major Manufacturers
Table 7. Oral Major Manufacturers
Table 8. Injection Major Manufacturers
Table 9. Pruritus Therapeutics Industry Trends
Table 10. Pruritus Therapeutics Industry Drivers
Table 11. Pruritus Therapeutics Industry Opportunities and Challenges
Table 12. Pruritus Therapeutics Industry Restraints
Table 13. Global Pruritus Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Pruritus Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Pruritus Therapeutics Market Share by Region (2019-2024)
Table 16. Global Pruritus Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Pruritus Therapeutics Market Share by Region (2025-2030)
Table 18. Global Pruritus Therapeutics Revenue by Players (US$ Million) & (2019-2024)
Table 19. Global Pruritus Therapeutics Revenue Market Share by Players (2019-2024)
Table 20. Global Pruritus Therapeutics Key Players Ranking, 2022 VS 2023 VS 2024
Table 21. Global Pruritus Therapeutics Key Players Headquarters & Area Served
Table 22. Global Pruritus Therapeutics Players, Product Type & Application
Table 23. Global Pruritus Therapeutics Players Commercialization Time
Table 24. Global Players Market Concentration Ratio (CR5 and HHI)
Table 25. Global Pruritus Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 26. Global Pruritus Therapeutics Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 28. Global Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 29. Global Pruritus Therapeutics Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 30. Global Pruritus Therapeutics Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 31. Global Pruritus Therapeutics Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 33. Global Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 34. Global Pruritus Therapeutics Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 35. Global Pruritus Therapeutics Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 36. J&J Company Information
Table 37. J&J Business Overview
Table 38. J&J Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 39. J&J Pruritus Therapeutics Product Portfolio
Table 40. J&J Recent Development
Table 41. Abbott Company Information
Table 42. Abbott Business Overview
Table 43. Abbott Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 44. Abbott Pruritus Therapeutics Product Portfolio
Table 45. Abbott Recent Development
Table 46. Amgen Company Information
Table 47. Amgen Business Overview
Table 48. Amgen Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 49. Amgen Pruritus Therapeutics Product Portfolio
Table 50. Amgen Recent Development
Table 51. LEO Pharma Company Information
Table 52. LEO Pharma Business Overview
Table 53. LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 54. LEO Pharma Pruritus Therapeutics Product Portfolio
Table 55. LEO Pharma Recent Development
Table 56. Novartis Company Information
Table 57. Novartis Business Overview
Table 58. Novartis Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 59. Novartis Pruritus Therapeutics Product Portfolio
Table 60. Novartis Recent Development
Table 61. Bayer Company Information
Table 62. Bayer Business Overview
Table 63. Bayer Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 64. Bayer Pruritus Therapeutics Product Portfolio
Table 65. Bayer Recent Development
Table 66. Pfizer Company Information
Table 67. Pfizer Business Overview
Table 68. Pfizer Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 69. Pfizer Pruritus Therapeutics Product Portfolio
Table 70. Pfizer Recent Development
Table 71. UCB Pharma Company Information
Table 72. UCB Pharma Business Overview
Table 73. UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 74. UCB Pharma Pruritus Therapeutics Product Portfolio
Table 75. UCB Pharma Recent Development
Table 76. GlaxoSmithKline Company Information
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 79. GlaxoSmithKline Pruritus Therapeutics Product Portfolio
Table 80. GlaxoSmithKline Recent Development
Table 81. Galderma Company Information
Table 82. Galderma Business Overview
Table 83. Galderma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 84. Galderma Pruritus Therapeutics Product Portfolio
Table 85. Galderma Recent Development
Table 86. Huapont Company Information
Table 87. Huapont Business Overview
Table 88. Huapont Pruritus Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Huapont Pruritus Therapeutics Product Portfolio
Table 90. Huapont Recent Development
Table 91. North America Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 92. North America Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 93. North America Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 94. North America Pruritus Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 95. North America Pruritus Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 96. Europe Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 97. Europe Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 98. Europe Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 99. Europe Pruritus Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 100. Europe Pruritus Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 101. China Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 102. China Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 103. Asia Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 104. Asia Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 105. Asia Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 106. Asia Pruritus Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 107. Asia Pruritus Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 108. MEALA Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 109. MEALA Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 110. MEALA Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 111. MEALA Pruritus Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 112. MEALA Pruritus Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 113. Research Programs/Design for This Report
Table 114. Authors List of This Report
Table 115. Secondary Sources
Table 116. Primary Sources
Table 1. Global Pruritus Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. Antihistamines Major Manufacturers
Table 2. Corticosteroids Major Manufacturers
Table 3. Calcineurin Inhibitors Major Manufacturers
Table 4. Others Major Manufacturers
Table 5. Global Pruritus Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 6. External Use Major Manufacturers
Table 7. Oral Major Manufacturers
Table 8. Injection Major Manufacturers
Table 9. Pruritus Therapeutics Industry Trends
Table 10. Pruritus Therapeutics Industry Drivers
Table 11. Pruritus Therapeutics Industry Opportunities and Challenges
Table 12. Pruritus Therapeutics Industry Restraints
Table 13. Global Pruritus Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 14. Global Pruritus Therapeutics Market Size by Region (2019-2024) & (US$ Million)
Table 15. Global Pruritus Therapeutics Market Share by Region (2019-2024)
Table 16. Global Pruritus Therapeutics Market Size by Region (2025-2030) & (US$ Million)
Table 17. Global Pruritus Therapeutics Market Share by Region (2025-2030)
Table 18. Global Pruritus Therapeutics Revenue by Players (US$ Million) & (2019-2024)
Table 19. Global Pruritus Therapeutics Revenue Market Share by Players (2019-2024)
Table 20. Global Pruritus Therapeutics Key Players Ranking, 2022 VS 2023 VS 2024
Table 21. Global Pruritus Therapeutics Key Players Headquarters & Area Served
Table 22. Global Pruritus Therapeutics Players, Product Type & Application
Table 23. Global Pruritus Therapeutics Players Commercialization Time
Table 24. Global Players Market Concentration Ratio (CR5 and HHI)
Table 25. Global Pruritus Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 26. Global Pruritus Therapeutics Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 27. Global Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 28. Global Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Table 29. Global Pruritus Therapeutics Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 30. Global Pruritus Therapeutics Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 31. Global Pruritus Therapeutics Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 32. Global Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 33. Global Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Table 34. Global Pruritus Therapeutics Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 35. Global Pruritus Therapeutics Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 36. J&J Company Information
Table 37. J&J Business Overview
Table 38. J&J Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 39. J&J Pruritus Therapeutics Product Portfolio
Table 40. J&J Recent Development
Table 41. Abbott Company Information
Table 42. Abbott Business Overview
Table 43. Abbott Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 44. Abbott Pruritus Therapeutics Product Portfolio
Table 45. Abbott Recent Development
Table 46. Amgen Company Information
Table 47. Amgen Business Overview
Table 48. Amgen Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 49. Amgen Pruritus Therapeutics Product Portfolio
Table 50. Amgen Recent Development
Table 51. LEO Pharma Company Information
Table 52. LEO Pharma Business Overview
Table 53. LEO Pharma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 54. LEO Pharma Pruritus Therapeutics Product Portfolio
Table 55. LEO Pharma Recent Development
Table 56. Novartis Company Information
Table 57. Novartis Business Overview
Table 58. Novartis Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 59. Novartis Pruritus Therapeutics Product Portfolio
Table 60. Novartis Recent Development
Table 61. Bayer Company Information
Table 62. Bayer Business Overview
Table 63. Bayer Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 64. Bayer Pruritus Therapeutics Product Portfolio
Table 65. Bayer Recent Development
Table 66. Pfizer Company Information
Table 67. Pfizer Business Overview
Table 68. Pfizer Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 69. Pfizer Pruritus Therapeutics Product Portfolio
Table 70. Pfizer Recent Development
Table 71. UCB Pharma Company Information
Table 72. UCB Pharma Business Overview
Table 73. UCB Pharma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 74. UCB Pharma Pruritus Therapeutics Product Portfolio
Table 75. UCB Pharma Recent Development
Table 76. GlaxoSmithKline Company Information
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 79. GlaxoSmithKline Pruritus Therapeutics Product Portfolio
Table 80. GlaxoSmithKline Recent Development
Table 81. Galderma Company Information
Table 82. Galderma Business Overview
Table 83. Galderma Pruritus Therapeutics Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 84. Galderma Pruritus Therapeutics Product Portfolio
Table 85. Galderma Recent Development
Table 86. Huapont Company Information
Table 87. Huapont Business Overview
Table 88. Huapont Pruritus Therapeutics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Huapont Pruritus Therapeutics Product Portfolio
Table 90. Huapont Recent Development
Table 91. North America Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 92. North America Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 93. North America Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 94. North America Pruritus Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 95. North America Pruritus Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 96. Europe Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 97. Europe Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 98. Europe Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 99. Europe Pruritus Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 100. Europe Pruritus Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 101. China Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 102. China Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 103. Asia Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 104. Asia Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 105. Asia Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 106. Asia Pruritus Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 107. Asia Pruritus Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 108. MEALA Pruritus Therapeutics Revenue by Type (2019-2024) & (US$ Million)
Table 109. MEALA Pruritus Therapeutics Revenue by Application (2019-2024) & (US$ Million)
Table 110. MEALA Pruritus Therapeutics Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 111. MEALA Pruritus Therapeutics Revenue by Country (2019-2024) & (US$ Million)
Table 112. MEALA Pruritus Therapeutics Revenue by Country (2025-2030) & (US$ Million)
Table 113. Research Programs/Design for This Report
Table 114. Authors List of This Report
Table 115. Secondary Sources
Table 116. Primary Sources
LIST OF FIGURES
Figure 1. Pruritus Therapeutics Product Picture
Figure 2. Global Pruritus Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pruritus Therapeutics Market Size Share 2019 VS 2023 VS 2030
Figure 4. Antihistamines Picture
Figure 5. Corticosteroids Picture
Figure 6. Calcineurin Inhibitors Picture
Figure 7. Others Picture
Figure 8. Global Pruritus Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 9. Global Pruritus Therapeutics Market Size Share 2019 VS 2023 VS 2030
Figure 10. External Use Picture
Figure 11. Oral Picture
Figure 12. Injection Picture
Figure 13. Global Pruritus Therapeutics Market Size (US$ Million) & (2019-2030)
Figure 14. Global Pruritus Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Pruritus Therapeutics Market Share by Region: 2019 VS 2023 VS 2030
Figure 16. Global Pruritus Therapeutics Players Revenue Share Top 10 and Top 5 in 2023
Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. Global Pruritus Therapeutics Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Pruritus Therapeutics Revenue Market Share 2019 VS 2023 VS 2030
Figure 20. Global Pruritus Therapeutics Revenue Market Share by Type (2019-2030)
Figure 21. Global Pruritus Therapeutics Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Pruritus Therapeutics Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 23. Global Pruritus Therapeutics Revenue Market Share by Application (2019-2030)
Figure 24. North America Pruritus Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 26. North America Pruritus Therapeutics Revenue Share by Type (2019-2030)
Figure 27. North America Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 28. North America Pruritus Therapeutics Revenue Share by Application (2019-2030)
Figure 29. North America Pruritus Therapeutics Revenue Share by Country (2019-2030)
Figure 30. United States Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Canada Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Europe Pruritus Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 33. Europe Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 34. Europe Pruritus Therapeutics Revenue Share by Type (2019-2030)
Figure 35. Europe Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 36. Europe Pruritus Therapeutics Revenue Share by Application (2019-2030)
Figure 37. Europe Pruritus Therapeutics Revenue Share by Country (2019-2030)
Figure 38. Germany Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. France Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. U.K. Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Italy Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Russia Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Nordic Countries Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. China Pruritus Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 46. China Pruritus Therapeutics Revenue Share by Type (2019-2030)
Figure 47. China Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 48. China Pruritus Therapeutics Revenue Share by Application (2019-2030)
Figure 49. Asia Pruritus Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 50. Asia Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 51. Asia Pruritus Therapeutics Revenue Share by Type (2019-2030)
Figure 52. Asia Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 53. Asia Pruritus Therapeutics Revenue Share by Application (2019-2030)
Figure 54. Asia Pruritus Therapeutics Revenue Share by Country (2019-2030)
Figure 55. Japan Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. South Korea Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. India Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Australia Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. China Taiwan Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. Southeast Asia Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. MEALA Pruritus Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 62. MEALA Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 63. MEALA Pruritus Therapeutics Revenue Share by Type (2019-2030)
Figure 64. MEALA Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 65. MEALA Pruritus Therapeutics Revenue Share by Application (2019-2030)
Figure 66. MEALA Pruritus Therapeutics Revenue Share by Country (2019-2030)
Figure 67. Mexico Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. South Korea Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Brazil Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Israel Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Argentina Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Colombia Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Turkey Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Saudi Arabia Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. UAE Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Years Considered
Figure 77. Research Process
Figure 78. Key Executives Interviewed
Figure 1. Pruritus Therapeutics Product Picture
Figure 2. Global Pruritus Therapeutics Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Pruritus Therapeutics Market Size Share 2019 VS 2023 VS 2030
Figure 4. Antihistamines Picture
Figure 5. Corticosteroids Picture
Figure 6. Calcineurin Inhibitors Picture
Figure 7. Others Picture
Figure 8. Global Pruritus Therapeutics Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 9. Global Pruritus Therapeutics Market Size Share 2019 VS 2023 VS 2030
Figure 10. External Use Picture
Figure 11. Oral Picture
Figure 12. Injection Picture
Figure 13. Global Pruritus Therapeutics Market Size (US$ Million) & (2019-2030)
Figure 14. Global Pruritus Therapeutics Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Pruritus Therapeutics Market Share by Region: 2019 VS 2023 VS 2030
Figure 16. Global Pruritus Therapeutics Players Revenue Share Top 10 and Top 5 in 2023
Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 18. Global Pruritus Therapeutics Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Pruritus Therapeutics Revenue Market Share 2019 VS 2023 VS 2030
Figure 20. Global Pruritus Therapeutics Revenue Market Share by Type (2019-2030)
Figure 21. Global Pruritus Therapeutics Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Pruritus Therapeutics Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 23. Global Pruritus Therapeutics Revenue Market Share by Application (2019-2030)
Figure 24. North America Pruritus Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 25. North America Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 26. North America Pruritus Therapeutics Revenue Share by Type (2019-2030)
Figure 27. North America Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 28. North America Pruritus Therapeutics Revenue Share by Application (2019-2030)
Figure 29. North America Pruritus Therapeutics Revenue Share by Country (2019-2030)
Figure 30. United States Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 31. Canada Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 32. Europe Pruritus Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 33. Europe Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 34. Europe Pruritus Therapeutics Revenue Share by Type (2019-2030)
Figure 35. Europe Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 36. Europe Pruritus Therapeutics Revenue Share by Application (2019-2030)
Figure 37. Europe Pruritus Therapeutics Revenue Share by Country (2019-2030)
Figure 38. Germany Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. France Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. U.K. Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Italy Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. Russia Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 43. Nordic Countries Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 44. China Pruritus Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 45. China Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 46. China Pruritus Therapeutics Revenue Share by Type (2019-2030)
Figure 47. China Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 48. China Pruritus Therapeutics Revenue Share by Application (2019-2030)
Figure 49. Asia Pruritus Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 50. Asia Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 51. Asia Pruritus Therapeutics Revenue Share by Type (2019-2030)
Figure 52. Asia Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 53. Asia Pruritus Therapeutics Revenue Share by Application (2019-2030)
Figure 54. Asia Pruritus Therapeutics Revenue Share by Country (2019-2030)
Figure 55. Japan Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. South Korea Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. India Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Australia Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. China Taiwan Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 60. Southeast Asia Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 61. MEALA Pruritus Therapeutics Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 62. MEALA Pruritus Therapeutics Revenue by Type (2025-2030) & (US$ Million)
Figure 63. MEALA Pruritus Therapeutics Revenue Share by Type (2019-2030)
Figure 64. MEALA Pruritus Therapeutics Revenue by Application (2025-2030) & (US$ Million)
Figure 65. MEALA Pruritus Therapeutics Revenue Share by Application (2019-2030)
Figure 66. MEALA Pruritus Therapeutics Revenue Share by Country (2019-2030)
Figure 67. Mexico Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. South Korea Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Brazil Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Israel Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Argentina Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Colombia Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. Turkey Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Saudi Arabia Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 75. UAE Pruritus Therapeutics Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 76. Years Considered
Figure 77. Research Process
Figure 78. Key Executives Interviewed
